AI platform company Saama Technologies has announced that William H. Carson has been added to its Board of Directors. Dr. Carson will become the company’s seventh board member, effective October 16, 2020.
“As we continue to evolve Saama into the leading technology vendor of choice for accelerating drug development, Bill’s contributions will elevate the authoritative thinking for which Saama’s Board of Directors is known,” said Saama Technologies Founder and CEO Suresh Katta. “As a nationally recognized life sciences industry visionary, Bill will provide valuable perspectives as we continue to execute our strategy, drive profitability, enhance customer value, and help the industry expedite drug development and delivery. We look forward to his contributions and are excited to welcome him to the Saama team.”
Dr. Carson has more than 20 years of experience in business, healthcare and pharmaceutical industries, and was most recently President and CEO at Otsuka Pharmaceutical Development & Commercialization, Inc.. He remains Chairman of the Board at OPDC.
“Saama’s leadership position as the number one AI clinical analytics company in the market, coupled with its commitment to helping life science companies accelerate drug development, make it an exciting time to join the Saama Board of Directors,” said Dr. Carson. “I am excited to add my experience to the impressive brain trust that currently comprises the board, and begin working with my fellow members.”